Related Experiment Video
Updated: May 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
William M Wood1, Vibha Sharma, Kevin T Bauerle
1Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
Abstract:
Undifferentiated (anaplastic) thyroid cancer (ATC) is one of the most aggressive human malignancies and no effective therapy is currently available. We show here that PPARγ levels are elevated in cells derived from ATC. Depletion of PPARγ in HTh74 ATC cells resulted in decreased cell growth, cell cycle arrest and a reduction in pRb and cyclin A and B1 levels. We further showed that both flank and orthotopic thyroid tumors derived from PPARγ-depleted cells grew more slowly than PPARγ-expressing cells. When PPARγ was overexpressed in more differentiated thyroid cancer BCPAP cells which lack PPARγ, there was increased growth and raised pRb and cyclin A and B1 levels. Finally, PPARγ depletion in ATC cells decreased their invasive capacity whereas overexpression in PTC cells increased invasiveness. These data suggest that PPARγ may play a detrimental role in thyroid cancer and that targeting it therapeutically may lead to improved treatment of advanced thyroid cancer.
Insights
Elevated PPARγ drives aggressive thyroid cancer growth and invasiveness. Targeting PPARγ may offer a new therapeutic strategy for advanced thyroid cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Undifferentiated (anaplastic) thyroid cancer (ATC) is highly aggressive with limited therapeutic options.
- PPARγ (peroxisome proliferator-activated receptor gamma) levels are elevated in ATC cells.
Purpose of the Study:
- To investigate the role of PPARγ in thyroid cancer progression and invasiveness.
- To explore the therapeutic potential of targeting PPARγ in advanced thyroid cancer.
Main Methods:
- PPARγ depletion using RNA interference in HTh74 ATC cells.
- PPARγ overexpression in BCPAP differentiated thyroid cancer cells.
- Assessment of cell growth, cell cycle, protein levels (pRb, cyclin A, B1), and tumor growth in vivo.
- Evaluation of cellular invasiveness.
Main Results:
- PPARγ depletion reduced ATC cell growth, induced cell cycle arrest, and decreased pRb and cyclin levels.
- PPARγ depletion slowed both flank and orthotopic tumor growth.
- PPARγ overexpression in differentiated cells increased growth and pRb/cyclin levels.
- PPARγ depletion decreased ATC cell invasiveness, while overexpression increased invasiveness in differentiated cells.
Conclusions:
- PPARγ plays a detrimental role in thyroid cancer, promoting growth and invasiveness.
- Targeting PPARγ represents a potential therapeutic strategy for advanced thyroid cancer.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Abnormal Proliferation
Abnormal Proliferation
